Relief Therapeutics Holding SA (SWX: RLF)
Switzerland
· Delayed Price · Currency is CHF 3.840
+0.890 (30.17%)
Oct 8, 2024, 3:09 PM CET
RLF Revenue
Relief Therapeutics Holding had revenue of 3.01M CHF in the half year ending December 31, 2023, a decrease of -9.36%. This brings the company's revenue in the last twelve months to 8.60M, up 45.04% year-over-year. In the year 2023, Relief Therapeutics Holding had annual revenue of 6.03M, down -0.79%.
Revenue (ttm)
8.60M
Revenue Growth
+45.04%
P/S Ratio
4.28
Revenue / Employee
175.47K
Employees
49
Market Cap
36.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Roche Holding AG | 60.58B |
| Novartis AG | 43.91B |
| Lonza Group AG | 6.70B |
| Straumann Holding AG | 2.54B |
| Galderma Group AG | 3.88B |
| Sonova Holding AG | 3.63B |
| Ypsomed Holding AG | 548.46M |
Relief Therapeutics Holding News
- 3 days ago - Relief gains as experimental therapy performs on par with BioMarin’s Kuvan - Seeking Alpha
- 20 days ago - Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 - Accesswire
- 5 weeks ago - Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 - Accesswire
- 5 weeks ago - Relief Therapeutics reports 1H results - Seeking Alpha
- 5 weeks ago - Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update - Accesswire
- 2 months ago - Relief Therapeutics Secures up to $11 Million from Royalty Sales - Accesswire
- 3 months ago - RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting - Accesswire
- 4 months ago - Relief Therapeutics Announces Executive Changes - Accesswire